|
This study, published in the journal Rheumatology, looked at "working status in patients with RA, AS and PsA treated with anti-TNF therapy registered with the British Society for Rheumatology Biologics Register."
The authors of the study found that, "At baseline, work disability rates were already high: 49% for RA, 39% for PsA, 41% for AS…" and that a "high percentage of patients with RA, AS and PsA were already work disabled at the start of anti-TNF therapy."
To read the study's abstract, click here.
|
Spondylitis Information
|
Donate to SAA
|
|
STAY INFORMED!
Stay up-to-date on all the latest news and information regarding AS and related diseases with our news magazine, Spondylitis Plus. Your subscription comes free with SAA membership, so click here to join today!
|
|